Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OMOSIA
- Development stage
- Unknown
- Lead developer
- Jiangsu Hongdou Pharmaceutical Technology
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
OMOSIA (澳希亚) is a brand of active folate (6S-5-methyltetrahydrofolate calcium) dietary supplements developed by Wuxi Taxus Pharmaceutical and its affiliate Jiangsu Hongdou Pharmaceutical Technology. The product line includes OMOSIA 6S-5-methyltetrahydrofolate calcium multivitamin tablets, zinc-selenium multivitamin tablets, and beetroot tablets. Unlike conventional folic acid, which requires a multi-step enzymatic conversion process involving methylenetetrahydrofolate reductase (MTHFR) to become active, 6S-5-methyltetrahydrofolate calcium is a highly bioavailable, active form of folate that can be directly absorbed and utilized by the body. This makes it particularly effective for individuals with MTHFR gene mutations or folate metabolism disorders. The supplements are used to support maternal health, prevent neural tube defects, regulate homocysteine levels, and promote overall nutritional well-being.
- Brand names
- OMOSIA澳希亚澳希亚6S-5-甲基四氢叶酸钙复合多维片澳希亚6S-5-甲基四氢叶酸钙甜菜根片澳希亚6S-5-甲基四氢叶酸钙锌硒多维片
- Other names
- 6S-5-methyltetrahydrofolate calcium6S-5-甲基四氢叶酸钙levomefolate calcium活性叶酸
02
Targets
FOLR1 (FRα)FOLR2 (Folate receptor beta)MTR (Methionine synthase)
Beyond the preview
Go deeper on OMOSIA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OMOSIA.